What the six lenses say about EMCURE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How EMCURE’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -0.3pp | -1.7pp | +1.3pp | +13.4pp | +24.2pp | +46.5pp |
Nifty 500 Broad-market baseline | -0.7pp | -1.7pp | +0.7pp | +9.8pp | +19.1pp | +42.7pp |
Sector Own-sector index | — | — | -1.7pp | -2.7pp | +4.7pp | +24.8pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
EMCURE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
EMCURE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,815 | 2,002 | 1,963 | 2,116 | 2,101 | 2,270 | 2,363 | 2,470 |
| ↳ change QoQ | — | +10.3% | -2.0% | +7.8% | -0.7% | +8.0% | +4.1% | +4.5% |
| EBITDA (₹cr) | 360 | 417 | 359 | 402 | 417 | 475 | 493 | 480 |
| EBITDA margin | 19.8% | 20.8% | 18.3% | 19.0% | 19.9% | 20.9% | 20.9% | 19.4% |
| PAT (₹cr) | 153 | 202 | 156 | 197 | 215 | 251 | 231 | 244 |
| ↳ change QoQ | — | +32.1% | -22.6% | +26.2% | +9.1% | +16.7% | -8.0% | +5.6% |
| Net margin | 8.4% | 10.1% | 8.0% | 9.3% | 10.2% | 11.1% | 9.8% | 9.9% |
| EPS (₹) | 7.95 | 10.33 | 8.12 | 9.97 | 10.92 | 12.84 | 12.16 | 12.84 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding EMCURE (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Kotak Midcap Reg Gr | 0.98% | 67,611 | |
| Nippon India Multi Cap Dir Bns | 0.58% | 54,585 | |
| Nippon India Multi Cap Gr | 0.58% | 54,585 | |
| Nippon India Multi Cap Bns | 0.58% | 54,585 | |
| SBI Flexicap Reg Gr | 0.91% | 22,685 | |
| HSBC Small Cap Fund Reg Gr | 0.75% | 16,877 | |
| Aditya BSL ELSS Tax Saver Gr | 1.61% | 14,249 | |
| Aditya BSL ELSS Tax Saver Gr LSP | 1.61% | 14,249 | |
| Nippon India Pharma Gr | 1.52% | 9,044 | |
| Nippon India Pharma Bns | 1.52% | 9,044 |
ETFs holding EMCURE (0)
No tracked ETF holds EMCURE ≥0.5%.